Oncode Institute is a Dutch cancer research and innovation organization dedicated to accelerating breakthroughs in cancer research and translating them into meaningful diagnostics and treatments. By bringing together leading researchers across the Netherlands, Oncode strengthens the connection between discovery, clinical practice and real-world impact for patients.
The Netherlands Cancer Institute currently hosts 17 Oncode research groups. Through this collaboration, NKI researchers contribute to a national ecosystem that advances high-risk, high-gain cancer research and helps move new insights closer to application.
